Kevin Spelman, PhD, MCPP, RH(AHG), is a clinician and researcher whose expertise lies in botanical medicine/phytotherapy. His experience includes 3 decades of clinical work (Ayurveda & western phytotherapy), professorships (MCPHS, NUNM, MUIH, Bastyr, SCNM) and a decade of laboratory & clinical research. He was a cofounder of the first accredited Master’s degree in Clinical Herbal Medicine and formerly a postdoctoral fellow at the NIH researching the molecular biology of brain (Trifolium) and ovarian cancer (Ceanothus). He also identified novel cannabimimetic ligands from Zanthoxylum spp. while at NIH. His past research on Echinacea connected pharmacological targets for metabolic and immunological function and elucidated a novel target for the alkylamides that is now known to be part of the endocannabinoid system. Recent research includes the consideration of flavonoids in infectious diseases, medicinal plant extractions (percolation vs. maceration) and safety research on cannabinoids. Dr. Spelman is a frequent lecturer and has provided over 150 guest lecturers at various hospitals and conferences. He currently runs Health, Education & Research, a consulting company for research, new product development, novel formulations and phytochemical applications.